Zimmerman et al 1 report a multicenter study of the predictive power of biochemical markers for a diagnosis of myocardial infarction (MI) in 955 patients presenting with chest pain. MI diagnosis was based on creatine kinase (CK)-MB mass (7 ng/mL) and CK-MB index (2.5%) within 24 hours after emergency department arrival. Markers included CK-MB subforms, myoglobin, troponin T, troponin I, total CK-MB activity, and total CK-MB mass. Sensitivity and specificity are illustrated for hours 2, 4, 6, 10, 14, 18, and 22 after symptom onset. The authors report that CK-MB subforms, followed by myoglobin, were the most sensitive and specific for early diagnosis (ie, within 6 hours); they conclude that in the selection of a single assay, CK-MB subforms provide the earliest diagnosis.
ϩPVϭ
Seϫ12.5 Seϫ12.5ϩ(100ϪSp)ϫ87.5 ϫ100 ϪPVϭ Spϫ87.5 Spϫ87.5ϩ(100ϪSe)ϫ12.5 ϫ100 where 12.5 is the population frequency of MI in percent and 87.5 is its complement. Se indicates sensitivity and Sp, specificity.
The predictive values yield the following observations: (1) ϩPV at hours 2, 4, and 6 for troponins I and T, CK-MB activity, and CK-MB mass is greater (PϽ0.01) than that for CK-MB subforms and myoglobin; (2) ϪPV at 2 and 4 hours for the CK subforms is not significantly different from the other markers; and (3) ϪPV of the CK-MB subforms at 6 hours is significantly higher than that of all other markers (PϽ0.01).
By predictive value analysis, CK-MB subforms have no greater early rule-in power for MI than troponins T and I, CK-MB activity, and CK-MB mass; CK-MB subforms have the highest rule-out power only at the sixth hour after chest pain onset.
